MiNK-215

N/A

Report date: 2024/10/17 10:31:09

Base Information

Drug NameMiNK-215
Drug Alias NameFAP-CAR-iNKT (MiNK Therapeutics)Allo-FAP-CAR-iNKT (MiNK Therapeutics)Stromal Target-CAR-iNKT (MiNK Therapeutics)Stromal-CAR (MiNK Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunologic cytotoxicityInterleukin-15 stimulantsImmunostimulants +[4] 
TargetsInterleukin-15
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMiNK Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAutonomous Therapeutics IncMiNK Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A